Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)
ID: 357309Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed)" aimed at advancing the development of innovative brain stimulation devices for mental health treatment. This initiative seeks applications that either create novel devices or significantly enhance existing FDA-approved devices through hardware and software improvements, focusing on increased precision and effectiveness in treatment. The funding underscores the importance of multidisciplinary collaboration in neuroscience and engineering, with an emphasis on innovative approaches rather than incremental changes. Interested applicants can find more information and submit proposals by January 7, 2028, with no budget cap but a maximum project duration of five years. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-25-287.html.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has issued a Notice of Funding Opportunity (NOFO) focused on the development of advanced neuromodulation and neurostimulation devices for mental health applications (Funding Opportunity Number PAR-25-287). The initiative aims to stimulate innovation by funding projects that either create novel brain stimulation devices or significantly enhance existing FDA-approved devices. The application process encourages multidisciplinary teams to integrate expertise from neuroscience, engineering, and regulatory affairs. Proposals may include hardware/software development, preclinical testing, and must include a Plan for Enhancing Diverse Perspectives (PEDP) to foster inclusivity. The submission deadlines are set from January 5, 2025, with various review cycles extending through 2028. While budgets are not capped, they must reflect project needs, and projects can last a maximum of five years. NIH policies govern the applications, which must emphasize innovative and significant improvements in brain stimulation techniques while avoiding incremental changes. This funding opportunity underscores the NIH’s mission to transform mental health treatment through advanced research and technology development.
    Similar Opportunities
    Loading similar opportunities...